COMMUNIQUÉS West-GlobeNewswire

Oragenics, Inc. Announces Closing of Public Offering
05/09/2024
SARASOTA, Fla., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced [...]
Nyxoah to Participate in Upcoming Investor Conferences
05/09/2024
Nyxoah to Participate in Upcoming Investor Conferences Mont-Saint-Guibert, Belgium – September 5, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical [...]
Nyxoah Participera à de Prochaines Conférences d'Investisseurs
05/09/2024
Nyxoah Participera à de Prochaines Conférences d'Investisseurs Mont-Saint-Guibert, Belgique – 5 septembre 2024, 22:30 CET / 16:30 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société ») opère dans [...]
Aptose Announces Results from Special Meeting of Shareholders
05/09/2024
SAN DIEGO and TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing tuspetinib, a highly [...]
Lifecore Biomedical to Participate in 17th Annual Barrington Research Virtual Fall Investment Conference
05/09/2024
CHASKA, Minn., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced [...]
Celularity to Present at H.C. Wainwright’s 26th Annual Global Investment Conference
05/09/2024
FLORHAM PARK, N.J., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies and advanced [...]
Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update
05/09/2024
Announced new U.S.-based leadership with the appointment of Barry Quart, Pharm.D. as Chief Executive Officer (CEO) and David Szekeres as President Connect’s new management is currently evaluating the future clinical [...]
MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference
05/09/2024
ROCKVILLE, Md., Sept. 05, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and [...]
Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference
05/09/2024
HOLLISTON, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be [...]
Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators
05/09/2024
SILVER SPRING, Md., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix products, today announced a landmark achievement with the first-ever patient implant of [...]
PRESS RELEASE: Canadian doctor to the stars, Dr. Adeel Khan, launches his first global regenerative health clinic in Mississauga, Ontario
05/09/2024
MISSISSAUGA, Ontario, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Regenerative medicine specialist Dr. Adeel Khan, has gained global recognition for his groundbreaking therapies, treating high profile clients including actor/ [...]
New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies
05/09/2024
Trem-cel + Mylotarg demonstrated engraftment, shielding, broadened therapeutic window, and patient benefit VCAR33 ALLO demonstrates encouraging biomarker data at lowest dose New asset VADC45 with significant potential [...]
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/09/2024
WESTLAKE VILLAGE, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology [...]
Cytokinetics Announces Two Presentations at the 2024 American College of Clinical Pharmacology Annual Meeting
05/09/2024
Full Data from Phase 1 Study of CK-4021586 to be Presented on September 8, 2024 SOUTH SAN FRANCISCO, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced two presentations [...]
Aurora Spine Corporation to Attend Latin America Pain Society (LAPS) Conference, Showcasing Innovations in Pain Management and Spine Care for Emerging Markets
05/09/2024
CARLSBAD, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal [...]
National Toxicology Program Report Confirms Fluoride Exposure Harms Children's IQ
05/09/2024
LAKELAND, Fla., Sept. 05, 2024 (GLOBE NEWSWIRE) -- The National Toxicology Program’s (NTP) recent report on fluoride neurotoxicity , provides compelling scientific evidence that fluoride exposure is consistently [...]
Simulated Environment Concepts, Inc. Executes a Letter of Intent (LOI) Concerning a Prospective Merger With CMR Construction & Roofing, LLC, Recognized as One of the Leading Roofing Firms in North America
05/09/2024
NASHVILLE, TN, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Simulated Environment Concepts, Inc. (OTC: SMEV or Simulated) and CMR Construction & Roofing LLC (referred to as "CMR") are pleased to announce the execution of a [...]
Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association
05/09/2024
Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association Halle (Saale) / Munich, Germany, September 5, 2024 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; [...]
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
05/09/2024
COPENHAGEN, Denmark, September 5, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial [...]

Pages